BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7990702)

  • 1. Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease.
    Kahri J; Syvänne M; Taskinen MR
    Metabolism; 1994 Dec; 43(12):1498-502. PubMed ID: 7990702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
    Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
    Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
    Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
    Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
    J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.
    Syvänne M; Ahola M; Lahdenperä S; Kahri J; Kuusi T; Virtanen KS; Taskinen MR
    J Lipid Res; 1995 Mar; 36(3):573-82. PubMed ID: 7775869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
    Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
    Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the activity of the human cholesteryl ester transfer protein by carboxylated derivatives. Evidence for 13-cis-retinoic acid as a potent activator of the protein's activity in plasma.
    Florentin E; Athias A; Lagrost L
    Eur J Biochem; 1996 Sep; 240(3):699-706. PubMed ID: 8856073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
    Syvänne M; Hilden H; Taskinen MR
    J Lipid Res; 1994 Jan; 35(1):15-26. PubMed ID: 8138716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A; Sammett D; Granot E
    J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pancreas transplantation on distribution and composition of plasma lipoproteins.
    Föger B; Königsrainer A; Palos G; Ritsch A; Tröbinger G; Menzel HJ; Lechleitner M; Doblinger A; König P; Utermann G; Margreiter R; Patsch JR
    Metabolism; 1996 Jul; 45(7):856-61. PubMed ID: 8692021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity.
    Groener JE; da Col PG; Kostner GM
    Biochem J; 1987 Feb; 242(1):27-31. PubMed ID: 3593240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.
    de Vries R; Perton FG; Dallinga-Thie GM; van Roon AM; Wolffenbuttel BH; van Tol A; Dullaart RP
    Diabetes; 2005 Dec; 54(12):3554-9. PubMed ID: 16306375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition.
    Yamashita S; Hui DY; Wetterau JR; Sprecher DL; Harmony JA; Sakai N; Matsuzawa Y; Tarui S
    Metabolism; 1991 Jul; 40(7):756-63. PubMed ID: 1870431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridemic non-insulin-dependent diabetic patients.
    Durlach V; Attia N; Zahouani A; Leutenegger M; Girard-Globa A
    Atherosclerosis; 1996 Feb; 120(1-2):155-65. PubMed ID: 8645357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid.
    Arii K; Suehiro T; Yamamoto M; Ito H; Hashimoto K
    Metabolism; 1997 Oct; 46(10):1166-70. PubMed ID: 9322801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
    Tornvall P; Karpe F; Proudler A; Båvenholm P; Landou C; Olivecrona T; Hamsten A
    Metabolism; 1996 Nov; 45(11):1375-82. PubMed ID: 8931642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes.
    Dullaart RP; Riemens SC; Scheek LM; Van Tol A
    Eur J Clin Invest; 1999 Aug; 29(8):663-71. PubMed ID: 10457149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.